Company / SG&A per Share
IRADIMED CORP SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.40
FY2025
5-year range
$0.78 / $1.40
FY2021-FY2025
Trend
+11.1%
vs FY2024
Sector context
#125 of 156
Health Care
What the data says
IRADIMED CORP's sg&a per share of $1.40 is lower than 80% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 3 consecutive years, from $0.78 in FY2022 to $1.40 in FY2025.
Based on SEC 10-K filings.
1.40 in FY2025 with a 5-year CAGR of +6.1%.
Increased from $1.20 to $1.40 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +21.7%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 156This company $1.40 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- IRADIMED CORP's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 11.1% year-over-year.
- Ranks #125 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.40 | +11.1% |
| FY2024 | $1.26 | +4.8% |
| FY2023 | $1.20 | +54.8% |
| FY2022 | $0.78 | -8.6% |
| FY2021 | $0.85 | -18.6% |
| FY2020 | $1.04 | +9.6% |
| FY2019 | $0.95 | +14.6% |
| FY2018 | $0.83 | +14.5% |
| FY2017 | $0.72 | +68.1% |
| FY2016 | $0.43 | -3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026